Literature DB >> 17614826

Expression of the gamma-globin gene is sustained by the cAMP-dependent pathway in beta-thalassaemia.

Lakiea Bailey1, Yuichi Kuroyanagi, Carla F Franco-Penteado, Nicola Conran, Fernando F Costa, Sabrina Ausenda, Maria D Cappellini, Tohru Ikuta.   

Abstract

The present study found that the cyclic adenosine monophosphate (cAMP)-dependent pathway efficiently induced gamma-globin expression in adult erythroblasts, and this pathway plays a role in gamma-globin gene (HBG) expression in beta-thalassaemia. Expression of HBG mRNA increased to about 46% of non-HBA mRNA in adult erythroblasts treated with forskolin, while a cyclic guanosine monophosphate (cGMP) analogue induced HBG mRNA to levels <20% of non-HBA mRNA. In patients with beta-thalassaemia intermedia, cAMP levels were elevated in both red blood cells and nucleated erythroblasts but no consistent elevation was found with cGMP levels. The transcription factor cAMP response element binding protein (CREB) was phosphorylated in nucleated erythroblasts and its phosphorylation levels correlated with HBG mRNA levels of the patients. Other signalling molecules, such as mitogen-activated protein kinases and signal transducers and activators of transcription proteins, were phosphorylated at variable levels and showed no correlations with the HBG mRNA levels. Plasma levels of cytokines, such as erythropoietin, stem cell factor and transforming growth factor-beta were increased in patients, and these cytokines induced both HBG mRNA expression and CREB phosphorylation. These results demonstrate that the cAMP-dependent pathway, the activity of which is augmented by multiple cytokines, plays a role in regulating HBG expression in beta-thalassaemia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17614826     DOI: 10.1111/j.1365-2141.2007.06673.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  9 in total

1.  The proinflammatory cytokine GM-CSF downregulates fetal hemoglobin expression by attenuating the cAMP-dependent pathway in sickle cell disease.

Authors:  Tohru Ikuta; Adekunle D Adekile; Diana R Gutsaeva; James B Parkerson; Shobha D Yerigenahally; Betsy Clair; Abdullah Kutlar; Nadine Odo; C Alvin Head
Journal:  Blood Cells Mol Dis       Date:  2011-09-25       Impact factor: 3.039

2.  Inhibition of erythroblast growth and fetal hemoglobin production by ribofuranose-substituted adenosine derivatives.

Authors:  Natarajan V Bhanu; Y Terry Lee; Patricia A Oneal; Nicole M Gantt; Wulin Aerbajinai; Pierre Noel; Craig J Thomas; Jeffery L Miller
Journal:  Biochim Biophys Acta       Date:  2008-06-30

3.  Cytokine-mediated increases in fetal hemoglobin are associated with globin gene histone modification and transcription factor reprogramming.

Authors:  Orapan Sripichai; Christine M Kiefer; Natarajan V Bhanu; Toshihiko Tanno; Seung-Jae Noh; Sung-Ho Goh; J Eric Russell; Cheryl L Rognerud; Ching-Nan Ou; Patricia A Oneal; Emily R Meier; Nicole M Gantt; Colleen Byrnes; Y Terry Lee; Ann Dean; Jeffery L Miller
Journal:  Blood       Date:  2009-07-13       Impact factor: 22.113

4.  Lack of the multidrug transporter MRP4/ABCC4 defines the PEL-negative blood group and impairs platelet aggregation.

Authors:  Slim Azouzi; Mahmoud Mikdar; Patricia Hermand; Emilie-Fleur Gautier; Virginie Salnot; Alexandra Willemetz; Gaël Nicolas; Cédric Vrignaud; Alexandre Raneri; Patrick Mayeux; Christine Bole-Feysot; Patrick Nitschké; Jean-Pierre Cartron; Yves Colin; Olivier Hermine; Gabriele Jedlitschky; Marc Cloutier; Jessica Constanzo-Yanez; Carole Ethier; Nancy Robitaille; Maryse St-Louis; Caroline Le Van Kim; Thierry Peyrard
Journal:  Blood       Date:  2020-02-06       Impact factor: 22.113

5.  Nitric Oxide-cGMP Signaling Stimulates Erythropoiesis through Multiple Lineage-Specific Transcription Factors: Clinical Implications and a Novel Target for Erythropoiesis.

Authors:  Tohru Ikuta; Hassan Sellak; Nadine Odo; Adekunle D Adekile; Karin M L Gaensler
Journal:  PLoS One       Date:  2016-01-04       Impact factor: 3.240

6.  A common signaling pathway is activated in erythroid cells expressing high levels of fetal hemoglobin: a potential role for cAMP-elevating agents in β-globin disorders.

Authors:  Tohru Ikuta; Yuichi Kuroyanagi; Nadine Odo; Siyang Liu
Journal:  J Blood Med       Date:  2013-12-04

7.  Globin gene expression in correlation with G protein-related genes during erythroid differentiation.

Authors:  Vladan P Čokić; Reginald D Smith; Angélique Biancotto; Constance T Noguchi; Raj K Puri; Alan N Schechter
Journal:  BMC Genomics       Date:  2013-02-20       Impact factor: 3.969

8.  Serum of sickle cell disease patients contains fetal hemoglobin silencing factors secreted from leukocytes.

Authors:  Tohru Ikuta; Hassan Sellak; Si-Yang Liu; Nadine Odo
Journal:  J Blood Med       Date:  2018-06-22

9.  Proteomic Studies for the Investigation of γ-Globin Induction by Decitabine in Human Primary Erythroid Progenitor Cultures.

Authors:  Andria Theodorou; Marios Phylactides; Eleni Katsantoni; Kostas Vougas; Spyros D Garbis; Pavlos Fanis; Maria Sitarou; Swee Lay Thein; Marina Kleanthous
Journal:  J Clin Med       Date:  2020-01-03       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.